ÂÜÀòÂÒÂ×

Yujiro S. H. is a distinguished biotechnology leader with extensive experience in oncology and anti-viral therapeutics. As the CEO and Founder of IDEAYA Biosciences since June 2015, Yujiro has spearheaded initiatives in synthetic lethality and precision medicine, leading the company's IPO on NASDAQ in May 2019 and securing partnerships with major pharmaceutical companies like GSK and Pfizer. Yujiro also serves on the Board of Directors for Enanta Pharmaceuticals and holds board membership at the University of California, San Diego, Moores Cancer Center. Previous roles include Chief Operating Officer at RAPT Therapeutics and Flexus Biosciences, as well as Vice President of Corporate Development at Onyx Pharmaceuticals, where contributions included the development of multiple FDA-approved therapies. Education credentials consist of an MBA from the Wharton School and a BA in Chemistry from Colorado College.